<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Sumner Farmer | Activity</title>
	<link>https://brycefoster.com/members/drakeronald5/activity/</link>
	<atom:link href="https://brycefoster.com/members/drakeronald5/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Sumner Farmer.</description>
	<lastBuildDate>Wed, 06 May 2026 18:42:38 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">45f3e072d290cc025753e0949fcb150c</guid>
				<title>Sumner Farmer posted an update: Ozempic Deals in Russia: A Comprehensive [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1364858/</link>
				<pubDate>Sat, 07 Mar 2026 10:35:07 +0000</pubDate>

									<content:encoded><![CDATA[<p>Ozempic Deals in Russia: A Comprehensive Overview</p>
<p>Recently, the pharmaceutical landscape has gone through substantial changes. Among the most notable developments has been the introduction of Ozempic (semaglutide), a medication utilized mainly for managing type 2 diabetes, with fringe benefits for weight loss. As the need for this drug&hellip;<span class="activity-read-more" id="activity-read-more-1364858"><a href="https://brycefoster.com/activity/p/1364858/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f909ca97eee761d9c48e41a4d0eb21b7</guid>
				<title>Sumner Farmer became a registered member</title>
				<link>https://brycefoster.com/activity/p/1364691/</link>
				<pubDate>Sat, 07 Mar 2026 10:02:13 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>